Vivos Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ANSON FUNDS MANAGEMENT LP | 05/14/2025 | 242.58 K | $1.04 M | 0.00% | 2.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 57.35 K | $163.44 K | 27.93% | 0.67% |
| CUTTER & CO BROKERAGE, INC. | 05/01/2025 | 49.10 K | $139.94 K | 28.87% | 0.57% |
| VANGUARD GROUP INC | 05/09/2025 | 42.63 K | $121.51 K | 303.01% | 0.50% |
| ENVESTNET ASSET MANAGEMENT INC | 04/29/2025 | 38.87 K | $110.79 K | 100.00% | 0.45% |
| COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 34.00 K | $97.00 K | 30.77% | 0.40% |
| ROYAL BANK OF CANADA | 05/15/2025 | 18.00 K | $51.00 K | 100.00% | 0.21% |
| NORTHERN TRUST CORP | 05/13/2025 | 12.51 K | $35.66 K | 100.00% | 0.15% |
| STATE STREET CORP | 05/15/2025 | 11.82 K | $33.69 K | 100.00% | 0.14% |
| EWA, LLC | 04/22/2025 | 10.46 K | $29.82 K | 100.00% | 0.12% |
| CREDIT AGRICOLE S A | 05/14/2025 | 2.37 K | $6.74 K | 0.00% | 0.03% |
| UBS GROUP AG | 05/13/2025 | 1.88 K | $5.36 K | 383.03% | 0.02% |
| MORGAN STANLEY | 05/15/2025 | 1.31 K | $3.75 K | 1,675.68% | 0.02% |
| SIGNATUREFD, LLC | 05/02/2025 | 547 | $1.56 K | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 228 | $650 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 200 | $570 | -66.27% | 0.00% |
| RONALD BLUE TRUST, INC. | 04/21/2025 | 160 | $456 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 130 | $370 | 8.33% | 0.00% |
| KOZAK & ASSOCIATES, INC. | 04/15/2025 | 49 | $110 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/13/2025 | 8 | $23 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| STRATEGIC WEALTH INVESTMENT GROUP, LLC | 04/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vivos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Vivos Therapeutics, Inc.. The most heavily invested institutionals were:
Anson Funds Management LP: 242,583
GEODE CAPITAL MANAGEMENT, LLC: 57,349
Cutter & CO Brokerage, Inc.: 49,100
VANGUARD GROUP INC: 42,634
ENVESTNET ASSET MANAGEMENT INC: 38,873
COMMONWEALTH EQUITY SERVICES, LLC: 34,000
6.10% of Vivos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 524.24 K shares in the last 24 months. This purchase volume represents approximately $3.50 M in transactions.